Literature DB >> 32346746

Melanoma Genomics.

Julia Newton-Bishop, D Timothy Bishop, Mark Harland.   

Abstract

The incidence of cutaneous melanoma continues to increase in pale skinned peoples in Europe and elsewhere. Epidemiological studies identified genetically determined phenotypes such as pale skin, freckles and red hair, and sunburn as risk factors for this cancer. The development of many melanocytic naevi is also genetically determined and a strong melanoma risk phenotype. Not surprisingly then, genome wide association studies have identified pigmentation genes as common risk genes, and to a lesser extent, genes associated with melanocytic naevi. More unexpectedly, genes associated with telomere length have also been identified as risk genes. Higher risk susceptibility genes have been identified, particularly CDKN2A as the most common cause, and very rarely genes such as CDK4, POT1, TERT and other genes in coding for proteins in the shelterin complex are found to be mutated. Familial melanoma genes are associated with an increased number of melanocytic naevi but not invariably and the atypical naevus phenotype is therefore an imperfect marker of gene carrier status. At a somatic level, the most common driver mutation is BRAF, second most common NRAS, third NF1 and increasing numbers of additional rarer mutations are being identified such as in TP53. It is of note that the BRAF and NRAS mutations are not C>T accepted as characteristic of ultraviolet light induced mutations.

Entities:  

Keywords:  melanoma; somatic mutations; susceptibility genes

Mesh:

Substances:

Year:  2020        PMID: 32346746      PMCID: PMC9189746          DOI: 10.2340/00015555-3493

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   3.875


  39 in total

1.  Association of the POT1 Germline Missense Variant p.I78T With Familial Melanoma.

Authors:  Kim Wong; Carla Daniela Robles-Espinoza; David Rodriguez; Saskia S Rudat; Susana Puig; Miriam Potrony; Chi C Wong; James Hewinson; Paula Aguilera; Joan Anton Puig-Butille; Brigitte Bressac-de Paillerets; Hélène Zattara; Louise van der Weyden; Christopher D M Fletcher; Thomas Brenn; Mark J Arends; Víctor Quesada; Julia A Newton-Bishop; Carlos Lopez-Otin; D Timothy Bishop; Paul W Harms; Timothy M Johnson; Alison B Durham; David B Lombard; David J Adams
Journal:  JAMA Dermatol       Date:  2019-05-01       Impact factor: 10.282

Review 2.  Cutaneous malignant melanoma in survivors of heritable retinoblastoma.

Authors:  E I Traboulsi; L E Zimmerman; H J Manz
Journal:  Arch Ophthalmol       Date:  1988-08

3.  Features associated with germline CDKN2A mutations: a GenoMEL study of melanoma-prone families from three continents.

Authors:  Alisa M Goldstein; May Chan; Mark Harland; Nicholas K Hayward; Florence Demenais; D Timothy Bishop; Esther Azizi; Wilma Bergman; Giovanna Bianchi-Scarra; William Bruno; Donato Calista; Lisa A Cannon Albright; Valerie Chaudru; Agnes Chompret; Francisco Cuellar; David E Elder; Paola Ghiorzo; Elizabeth M Gillanders; Nelleke A Gruis; Johan Hansson; David Hogg; Elizabeth A Holland; Peter A Kanetsky; Richard F Kefford; Maria Teresa Landi; Julie Lang; Sancy A Leachman; Rona M MacKie; Veronica Magnusson; Graham J Mann; Julia Newton Bishop; Jane M Palmer; Susana Puig; Joan A Puig-Butille; Mitchell Stark; Hensin Tsao; Margaret A Tucker; Linda Whitaker; Emanuel Yakobson
Journal:  J Med Genet       Date:  2006-08-11       Impact factor: 6.318

4.  TERT promoter mutations in familial and sporadic melanoma.

Authors:  Susanne Horn; Adina Figl; P Sivaramakrishna Rachakonda; Christine Fischer; Antje Sucker; Andreas Gast; Stephanie Kadel; Iris Moll; Eduardo Nagore; Kari Hemminki; Dirk Schadendorf; Rajiv Kumar
Journal:  Science       Date:  2013-01-24       Impact factor: 47.728

Review 5.  Selection criteria for genetic assessment of patients with familial melanoma.

Authors:  Sancy A Leachman; John Carucci; Wendy Kohlmann; Kimberly C Banks; Maryam M Asgari; Wilma Bergman; Giovanna Bianchi-Scarrà; Teresa Brentnall; Brigitte Bressac-de Paillerets; William Bruno; Clara Curiel-Lewandrowski; Femke A de Snoo; Tadeusz Debniak; Marie-France Demierre; David Elder; Alisa M Goldstein; Jane Grant-Kels; Allan C Halpern; Christian Ingvar; Richard F Kefford; Julie Lang; Rona M MacKie; Graham J Mann; Kurt Mueller; Julia Newton-Bishop; Håkan Olsson; Gloria M Petersen; Susana Puig; Darrell Rigel; Susan M Swetter; Margaret A Tucker; Emanuel Yakobson; John A Zitelli; Hensin Tsao
Journal:  J Am Acad Dermatol       Date:  2009-10       Impact factor: 11.527

6.  GAB2 amplifications refine molecular classification of melanoma.

Authors:  Karen A Chernoff; Lindsey Bordone; Basil Horst; Katherine Simon; William Twadell; Keagan Lee; Jason A Cohen; Shuang Wang; David N Silvers; Georg Brunner; Julide Tok Celebi
Journal:  Clin Cancer Res       Date:  2009-06-09       Impact factor: 12.531

7.  Cutaneous malignant melanoma and familial dysplastic nevi: evidence for autosomal dominance and pleiotropy.

Authors:  S J Bale; A Chakravarti; M H Greene
Journal:  Am J Hum Genet       Date:  1986-02       Impact factor: 11.025

8.  Germline mutations in BAP1 predispose to melanocytic tumors.

Authors:  Thomas Wiesner; Anna C Obenauf; Rajmohan Murali; Isabella Fried; Klaus G Griewank; Peter Ulz; Christian Windpassinger; Werner Wackernagel; Shea Loy; Ingrid Wolf; Agnes Viale; Alex E Lash; Mono Pirun; Nicholas D Socci; Arno Rütten; Gabriele Palmedo; David Abramson; Kenneth Offit; Arthur Ott; Jürgen C Becker; Lorenzo Cerroni; Heinz Kutzner; Boris C Bastian; Michael R Speicher
Journal:  Nat Genet       Date:  2011-08-28       Impact factor: 38.330

9.  Genome-wide association study identifies a new melanoma susceptibility locus at 1q21.3.

Authors:  Stuart Macgregor; Grant W Montgomery; Jimmy Z Liu; Zhen Zhen Zhao; Anjali K Henders; Mitchell Stark; Helen Schmid; Elizabeth A Holland; David L Duffy; Mingfeng Zhang; Jodie N Painter; Dale R Nyholt; Judith A Maskiell; Jodie Jetann; Megan Ferguson; Anne E Cust; Mark A Jenkins; David C Whiteman; Håkan Olsson; Susana Puig; Giovanna Bianchi-Scarrà; Johan Hansson; Florence Demenais; Maria Teresa Landi; Tadeusz Dębniak; Rona Mackie; Esther Azizi; Brigitte Bressac-de Paillerets; Alisa M Goldstein; Peter A Kanetsky; Nelleke A Gruis; David E Elder; Julia A Newton-Bishop; D Timothy Bishop; Mark M Iles; Per Helsing; Christopher I Amos; Qingyi Wei; Li-E Wang; Jeffrey E Lee; Abrar A Qureshi; Richard F Kefford; Graham G Giles; Bruce K Armstrong; Joanne F Aitken; Jiali Han; John L Hopper; Jeffrey M Trent; Kevin M Brown; Nicholas G Martin; Graham J Mann; Nicholas K Hayward
Journal:  Nat Genet       Date:  2011-10-09       Impact factor: 38.330

10.  Genetic susceptibility to naevi--a twin study.

Authors:  D F Easton; G M Cox; A M Macdonald; B A Ponder
Journal:  Br J Cancer       Date:  1991-12       Impact factor: 7.640

View more
  2 in total

Review 1.  Defining the Criteria for Reflex Testing for BRAF Mutations in Cutaneous Melanoma Patients.

Authors:  Sarah Zhou; Daniel Sikorski; Honghao Xu; Andrei Zubarev; May Chergui; François Lagacé; Wilson H Miller; Margaret Redpath; Stephanie Ghazal; Marcus O Butler; Teresa M Petrella; Joël Claveau; Carolyn Nessim; Thomas G Salopek; Robert Gniadecki; Ivan V Litvinov
Journal:  Cancers (Basel)       Date:  2021-05-10       Impact factor: 6.639

Review 2.  Aetiology and Pathogenesis of Cutaneous Melanoma: Current Concepts and Advances.

Authors:  Strahil Strashilov; Angel Yordanov
Journal:  Int J Mol Sci       Date:  2021-06-15       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.